Skip to content

Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer

Ellen Kapiteijn, Corrie A.M. Marijnen, Irıs D. Nagtegaal, Hein Putter, Willem Hans Steup, Theo Wiggers, Harm J. T. Rutten, Lars Påhlman, Bengt L. G. Glimelius, J. Han van Krieken, J.W.H. Leer, Cornelis J.�H. van de Velde

New England Journal of Medicine · 2001 · 4,241 citationsOpen access

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Kapiteijn, E., Marijnen, C. A., Nagtegaal, I. D., Putter, H., Steup, W. H., Wiggers, T., Rutten, H. J. T., Påhlman, L., Glimelius, B. L. G., Krieken, J. H. van, Leer, J., & Velde, C. J. van de. (2001). Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. New England Journal of Medicine, 345(9), 638–646. https://doi.org/10.1056/nejmoa010580

In text: (Kapiteijn et al., 2001)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

BACKGROUND: Short-term preoperative radiotherapy and total mesorectal excision have each been shown to improve local control of disease in patients with resectable rectal cancer. We conducted a multicenter, randomized trial to determine whether the addition of preoperative radiotherapy increases the benefit of total mesorectal excision. METHODS: We randomly assigned 1861 patients with resectable rectal cancer either to preoperative radiotherapy (5 Gy on each of five days) followed by total mesorectal excision (924 patients) or to total mesorectal excision alone (937 patients). The trial was conducted with the use of standardization and quality-control measures to ensure the consistency of the radiotherapy, surgery, and pathological techniques. RESULTS: Of the 1861 patients randomly assigned to one of the two treatment groups, 1805 were eligible to participate. The overall rate of survival at two years among the eligible patients was 82.0 percent in the group assigned to both radiotherapy and surgery and 81.8 percent in the group assigned to surgery alone (P=0.84). Among the 1748 patients who underwent a macroscopically complete local resection, the rate of local recurrence at two years was 5.3 percent. The rate of local recurrence at two years was 2.4 percent in the radiotherapy-plus-surgery group and 8.2 percent in the surgery-only group (P<0.001). CONCLUSIONS: Short-term preoperative radiotherapy reduces the risk of local recurrence in patients with rectal cancer who undergo a standardized total mesorectal excision.

  1. Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer2004
  2. Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer2004
  3. Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature2015
  4. Colorectal cancer statistics, 20202020
  5. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer2004

Metadata from OpenAlex (CC0). Citations are generated from the published record.